Submitted:
23 July 2025
Posted:
24 July 2025
You are already at the latest version
Abstract
Keywords:
1. Background
2. Methods
2.1. Study Design
2.2. Study Protocol
2.3. Statistical Analysis
3. Results
3.1. The 36-Item Short Form Health Survey (SF-36)
| PF | RP | RE | VT | MH | SF | BP | GH | PCS | MCS | SF36 | |
| Means | 71,1 | 42,2 | 37,6 | 53,6 | 57,4 | 65,4 | 76,3 | 55,9 | 61,4 | 53,5 | 64,3 |
| Standard Deviation | 24,6 | 48,4 | 47,5 | 20,0 | 22,7 | 26,3 | 20,9 | 24,0 | 25,5 | 24,9 | 21,7 |
| Minimum | 0 | 0 | 0 | 10 | 16 | 13 | 23 | 0 | 14 | 14 | 20 |
| Maximum | 100 | 100 | 100 | 100 | 96 | 100 | 100 | 100 | 100 | 99 | 97 |
| Percentage of patients having an altered score (%) | 20 | 57.3 | 62.7 | 41.3 | 44 | 22.7 | 10.7 | 35.3 | 40.7 | 47.3 | 29.3 |
3.2. Analytic Study
|
Gender |
Education level |
Occupation |
Social insurance coverage |
Living environment |
Marital status |
||||||||||||||
| Men | women | p | Illiterate | instructed | P | Employed | Retried | Jobless | p | uncovered | covered | p | Rural | urban | P | Married | Single | P | |
| PF | 74,2 | 59,8 |
0.003 |
62,9 |
75,2 |
0,007 |
74,3 | 72,0 | 60,0 | 0,030 | 69,3 | 71,9 | 0,555 | 66,9 | 72,3 | 0,265 | 71,9 | 68,2 | 0,439 |
| RP | 48,3 | 19,5 |
0.001 |
37,0 |
44,7 |
0,357 |
47,0 | 50,0 | 15,7 | 0,006 | 39,1 | 43,5 | 0,611 | 42,4 |
42,1 |
0,973 | 41,2 | 45,6 | 0,641 |
| EL | 42,1 | 20,8 | 0.014 | 37,3 | 37,7 | 0,968 | 38,9 | 48,7 | 17,3 | 0,027 | 37,7 | 37,5 | 0,983 | 41,4 | 36,5 | 0,599 | 36,8 | 40,2 | 0,714 |
| VT | 55,9 | 44,8 | <0.001 | 53,8 | 53,5 | 0,920 | 50,4 | 64,2 | 48,1 | <0,001 | 52,1 | 54,2 | 0,543 | 52,0 | 54,0 | 0,605 | 53,8 | 52,6 | 0,762 |
| MH | 59,2 | 50,8 | 0.063 | 63,3 | 54,4 | 0,023 | 51.5 | 70,6 | 56,6 | <0,001 | 56,5 | 57,7 | 0,765 | 61,1 |
56,3 |
0,287 | 57,1 | 58,4 | 0,773 |
| SF | 68,5 | 53,9 | 0.005 | 68,8 | 63,8 | 0,274 | 62,9 | 77,2 | 56,0 | 0,002 | 63,6 | 66,2 | 0,572 | 68,6 | 64,5 | 0,438 | 64,2 | 69,5 | 0,306 |
| BP | 79,7 | 63,8 | <0001 | 69,8 | 79,6 | 0,006 | 77,1 | 82,7 | 64,7 | 0,002 | 72,9 | 77,9 | 0,209 | 72,4 | 77,4 | 0,225 | 76,4 | 76,0 | 0,924 |
| GH | 58,2 | 47,5 | 0.025 | 52,7 | 57,5 | 0,249 | 54,8 | 62,2 | 50,2 | 0,112 | 53,0 | 57,2 | 0,334 | 54,1 | 56,4 | 0,625 | 55,4 | 57,5 | 0,660 |
| PCS | 65,1 | 47,6 | <0.001 | 55,6 | 64,3 | 0,049 | 63,3 | 66,7 | 47,7 | 0,006 | 58,6 | 62,6 | 0,375 | 58,9 | 62,1 | 0,538 | 61,2 | 61,8 | 0,906 |
| MCS | 56,4 | 42,6 | 0.001 | 55,8 | 52,3 | 0,423 | 50,9 | 65,2 | 44,5 | 0,001 | 52,5 | 53,9 | 0,742 | 55,8 | 52,8 | 0,553 | 53,0 | 55,2 | 0,654 |
| SF-36 | 67,0 | 54,2 | 0.001 | 62,2 | 65,3 | 0,413 | 62,6 | 72,9 | 57,1 | 0,007 | 62,1 | 65,2 | 0,420 | 63,9 | 64,4 | 0,918 | 63,3 | 67,5 | 0,262 |
3.3. Multivariate Analysis
| Coefficients | standard Error | 95% CI | P | ||
| Gender | -10,3 | 6,31 | 0,10 | 2,13 | 0,103 |
| Occupation | -0,50 | 2,78 | 0,86 | 5,00 | 0,856 |
| Diabetes | -1,29 | 3,85 | 0,74 | 6,33 | 0,738 |
| Arterial Hypertension | -5,00 | 3,94 | 0,21 | 2,79 | 0,206 |
| Smoking | 0,20 | 4,66 | 0,97 | 9,42 | 0,967 |
| Chronic renal failure | -0,078 | 4,16 | 0,98 | 8,15 | 0,985 |
| Obesity | -26,0 | 3,47 | 0,00 | -19,2 | <0,001 |
| Number of hospitalizations | -7,04 | 4,13 | 0,09 | 1,13 | 0,091 |
| Hospitalisation for acute heart failure | -10,0 | 4,49 | 0,03 | -1,15 | 0,027 |
| Number of stents | 1,06 | 2,83 | 0,71 | 6,66 | 0,707 |
| LVEF | 6,15 | 3,29 | 0,06 | 0,37 | 0,064 |
| Physical activity | -0,90 | 3,96 | 0,82 | 6,93 | 0,821 |
| Optimal medical treatment | -2,13 | 4,55 | 0,64 | 6,85 | 0,639 |
| Therapeutic compliance | 0,414 | 4,80 | 0,93 | 9,90 | 0,931 |
| Coefficient | standard Error | 95% CI | P | ||
| Age | 0,92 | 0,23 | 0,47 | 1,37 | <0,001 |
| Gender | -5,79 | 6,77 | 19,18 | 7,60 | 0,394 |
| Occupation | -2,20 | 3,29 | -8,71 | 4,32 | 0,507 |
| Smoking | 0,86 | 4,56 | -8,16 | 9,89 | 0,851 |
| Obesity | -24,0 | 3,33 | -30,5 | 17,42 | <0,001 |
| Number of hospitalizations | 3,79 | 3,30 | -2,73 | 10,32 | 0,252 |
| Hospitalization for acute heart failure | -9,63 | 4,45 | -18,4 | -0,82 | 0,032 |
| LVEF | -3,75 | 3,06 | -9,81 | 2,30 | 0,223 |
| Cardiac event occurance in the previous 5 years | 4.49 | 2.19 | 0.16 | 8.83 | 0.042 |
| Coefficients | standard Error | 95% CI | P | ||
| Occupation | -1,05 | 2,04 | 5,09 | 2,98 | 0,608 |
| Diabetes | -1,63 | 2,84 | 7,24 | 3,98 | 0,568 |
| Smoking | 4,92 | 3,11 | 1,22 | 11,1 | 0,116 |
| Obesity | -25,3 | 2,74 | 30,8 | 19,9 | <0,001 |
| Number of hospitalizations | -3,53 | 3,27 | 10,0 | 2,93 | 0,282 |
| Hospitalization for acute heart failure | -9,38 | 3,57 | 16,4 | 2,31 | 0,010 |
| Number of stents | -0,02 | 2,26 | 4,49 | 4,45 | 0,993 |
| LVEF | -3,49 | 2,55 | 8,53 | 1,56 | 0,174 |
| Optimal medical treatment | -1,02 | 3,64 | 8,22 | 6,18 | 0,780 |
| Therapeutic compliance | -1,37 | 3,52 | 8,34 | 5,59 | 0,697 |
| Age | 0,48 | 0,17 | 0,15 | 0,81 | 0,005 |
4. Discussion
4.1. Factors Associated with the Deterioration of Health-Related Quality of Life
4.2. Obesity
4.3. Arterial Hypertension
4.4. Diabetes
4.5. Kidney Failure
4.6. Number of Hospitalizations
4.7. Cause of Hospitalization
4.8. Coronary Artery Status
4.9. Left Ventricular Ejection Fraction
4.10. Therapeutic Aspect
4.10.1. Physical Activity
4.10.2. Smoking Cessation
4.10.3. Medical Treatment and Therapeutic Compliance
4.11. Strenghts and Limitations
5. Conclusions
List of Abbreviations
Conflicts of Interest
References
- Gaidai O, Cao Y, Loginov S. Global Cardiovascular Diseases Death Rate Prediction. Curr Probl Cardiol. 2023, 48, 101622. [CrossRef]
- Muhammad I, He HG, Kowitlawakul Y, Wang W. Narrative review of health-related quality of life and its predictors among patients with coronary heart disease. Int J Nurs Pract. 2016, 22, 4–14. [CrossRef] [PubMed]
- Calkins DR, Rubenstein LV, Cleary PD, Davies AR, Jette AM, Fink A, et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med. 1991, 114, 451–4. [CrossRef] [PubMed]
- Pedersen SS, Martens EJ, Denollet J, Appels A. Poor health-related quality of life is a predictor of early, but not late, cardiac events after percutaneous coronary intervention. Psychosomatics. 2007, 48, 331–7. [CrossRef]
- Uchmanowicz I, Łoboz-Grudzień K. Factors influencing quality of life up to the 36th month follow-up after treatment of acute coronary syndrome by coronary angioplasty. Nurs Res Rev. 2015, 5, 23–31.
- Wang W, Lau Y, Chow A, Thompson DR, He HG. Health-related quality of life and social support among Chinese patients with coronary heart disease in mainland China. Eur J Cardiovasc Nurs. 2014, 13, 48–54. [CrossRef]
- Norris CM, Ghali WA, Galbraith PD, Graham MM, Jensen LA, Knudtson ML, et al. Women with coronary artery disease report worse health-related quality of life outcomes compared to men. Health Qual Life Outcomes. 2004, 2, 21. [CrossRef]
- Conradie A, Atherton J, Chowdhury E, Duong M, Schwarz N, Worthley S, et al. Health-Related Quality of Life (HRQoL) and the Effect on Outcome in Patients Presenting with Coronary Artery Disease and Treated with Percutaneous Coronary Intervention (PCI): Differences Noted by Sex and Age. J Clin Med. 2022, 11, 5231.
- Kristofferzon ML, Löfmark R, Carlsson M. Perceived coping, social support, and quality of life 1 month after myocardial infarction: a comparison between Swedish women and men. Heart Lung J Crit Care. 2005, 34, 39–50. [CrossRef]
- Norris CM, Spertus JA, Jensen L, Johnson J, Hegadoren KM, Ghali WA, et al. Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease. Circ Cardiovasc Qual Outcomes. 2008, 1, 123–30. [CrossRef] [PubMed]
- Oreel TH, Nieuwkerk PT, Hartog ID, Netjes JE, Vonk ABA, Lemkes J, et al. Gender differences in quality of life in coronary artery disease patients with comorbidities undergoing coronary revascularization. PLOS ONE. 2020, 15, e0234543.
- Regidor E, Barrio G, de la Fuente L, Domingo A, Rodriguez C, Alonso J. Association between educational level and health related quality of life in Spanish adults. J Epidemiol Community Health. 1999, 53, 75–82. [CrossRef]
- Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2021, 42, 3227–337.
- Beck CA, Joseph L, Bélisle P, Pilote L. Predictors of quality of life 6 months and 1 year after acute myocardial infarction. Am Heart J. 2001, 142, 271–9. [CrossRef]
- Hawkes AL, Patrao TA, Ware R, Atherton JJ, Taylor CB, Oldenburg BF. Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patients. BMC Cardiovasc Disord. 2013, 13, 69.
- Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. J Am Coll Cardiol. 2000, 35, 907–14. [CrossRef] [PubMed]
- Cf M de L, Hm K, V V, Cs W, Ta G, Lf B, et al. A population-based perspective of changes in health-related quality of life after myocardial infarction in older men and women. J Clin Epidemiol [Internet]. juill 1998 [cité 26 août 2024], 51(7). Disponible sur: https://pubmed.ncbi.nlm.nih.gov/9674668/.
- Failde I, Medina P, Ramirez C, Arana R. Construct and criterion validity of the SF-12 health questionnaire in patients with acute myocardial infarction and unstable angina. J Eval Clin Pract. 2010, 16, 569–73.
- Barbareschi G, Sanderman R, Kempen GIJM, Ranchor AV. Socioeconomic Status and the Course of Quality of Life in Older Patients with Coronary Heart Disease. Int J Behav Med. 2009, 16, 197–204.
- Johnson JA, Coons SJ. Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 1998, 7, 155–66.
- Crilley JG, Farrer M. Impact of first myocardial infarction on self-perceived health status. QJM Mon J Assoc Physicians. 2001, 94, 13–8.
- Wang W, Thompson DR, Ski CF, Liu M. Health-related quality of life and its associated factors in Chinese myocardial infarction patients. Eur J Prev Cardiol. 2014, 21, 321–9.
- Rumsfeld JS, Ho PM, Magid DJ, McCarthy M, Shroyer ALW, MaWhinney S, et al. Predictors of health-related quality of life after coronary artery bypass surgery. Ann Thorac Surg. 2004, 77, 1508–13.
- Barta Z, Harrison MJ, Wangrangsimakul T, Shelmerdine J, Teh LS, Pattrick M, et al. Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosus. Lupus. 2010, 19, 231–8.
- Rapuri PB, Gallagher JC, Smith LM. Smoking is a risk factor for decreased physical performance in elderly women. J Gerontol A Biol Sci Med Sci. 2007, 62, 93–100.
- Oreopoulos A, Padwal R, McAlister FA, Ezekowitz J, Sharma AM, Kalantar-Zadeh K, et al. Association between obesity and health-related quality of life in patients with coronary artery disease. Int J Obes 2005. 2010, 34, 1434–41.
- Lidell E, Höfer S, Saner H, Perk J, Hildingh C, Oldridge N. Health-related quality of life in European women following myocardial infarction: a cross-sectional study. Eur J Cardiovasc Nurs. 2015, 14, 326–33.
- Lavie CJ, Milani RV. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol. 1997, 79, 397–401.
- Wang W, Lopez V, Ying CS, Thompson DR. The psychometric properties of the Chinese version of the SF-36 health survey in patients with myocardial infarction in mainland China. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2006, 15, 1525–31.
- Uchmanowicz I, Loboz-Grudzien K, Jankowska-Polanska B, Sokalski L. Influence of diabetes on health-related quality of life results in patients with acute coronary syndrome treated with coronary angioplasty. Acta Diabetol. 2013, 50, 217–25. [Google Scholar] [CrossRef] [PubMed]
- Sherman AM, Shumaker SA, Kancler C, Zheng B, Reboussin DM, Legault C, et al. Baseline health-related quality of life in postmenopausal women with coronary heart disease: the Estrogen Replacement and Atherosclerosis (ERA) trial. J Womens Health 2002. 2003, 12, 351–62.
- Darvishpour A, Javadi-Pashaki N, Salari A, Sadeghi T, Taleshan-Nejad M. Factors associated with quality of life in patients undergoing coronary angioplasty. Int J Health Sci. 2017, 11, 35–41.
- Salazar A, Dueñas M, Fernandez-Palacin F, Failde I. Factors related to the evolution of Health Related Quality of Life in coronary patients. A longitudinal approach using Weighted Generalized Estimating Equations with missing data. Int J Cardiol. 2016, 223, 940–6.
- Munyombwe T, Hall M, Dondo TB, Alabas OA, Gerard O, West RM, et al. Quality of life trajectories in survivors of acute myocardial infarction: a national longitudinal study. Heart Br Card Soc. 2020, 106, 33–9.
- Oldridge N, Gottlieb M, Guyatt G, Jones N, Streiner D, Feeny D. Predictors of health-related quality of life with cardiac rehabilitation after acute myocardial infarction. J Cardpulm Rehabil. 1998, 18, 95–103.
- Smedt DD, Clays E, Annemans L, Doyle F, Kotseva K, Pająk A, et al. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: Results from the EUROASPIRE III survey. Int J Cardiol. 2013, 168, 898–903.
- Dias CC, Mateus P, Santos L, Mateus C, Sampaio F, Adão L, et al. Acute coronary syndrome and predictors of quality of life. Rev Port Cardiol. 2005, 24, 819–31.
- Failde II, Soto MM. Changes in health related quality of life 3 months after an acute coronary syndrome. BMC Public Health. 2006, 6, 18.
- Lee DTF, Choi KC, Chair SY, Yu DSF, Lau ST. Psychological distress mediates the effects of socio-demographic and clinical characteristics on the physical health component of health-related quality of life in patients with coronary heart disease. Eur J Prev Cardiol. 2014, 21, 107–16.
- Positive psychology differences and risk stratification between STEMI and NSTEMI [Internet]. [cité 2 oct 2024]. Disponible sur: https://esc365.escardio.org/journal/52969.
- Lewis EF, Li Y, Pfeffer MA, Solomon SD, Weinfurt KP, Velazquez EJ, et al. Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction). JACC Heart Fail. 2014, 2, 159–65.
- Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995, 273, 59–65.
- R E, C C, M R, G de G, D C, C D, et al. Indicators of myocardial dysfunction and quality of life, one year after acute infarction. Eur J Heart Fail [Internet]. oct 2001 [cité 2 oct 2024], 3(5). Disponible sur: https://pubmed.ncbi.nlm.nih.gov/11595604/.
- O A, A H, V K, M V, K P, A K, et al. Effects of Physical Activity on Aging Processes in Elderly Persons. 2019 [cité 3 oct 2024], Disponible sur: https://reposit.uni-sport.edu.ua/handle/787878787/1824.
- Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association [Internet]. [cité 3 oct 2024]. Disponible sur: https://www.ahajournals.org/doi/epub/10.1161/CIR.0000000000001052.
- Kontoangelos K, Soulis D, Soulaidopoulos S, Antoniou CK, Tsiori S, Papageorgiou C, et al. Health Related Quality of Life and Cardiovascular Risk Factors. Behav Med Wash DC. 2024, 50, 186–94.
- Dąbek J, Styczkiewicz M, Kamiński K, Kubica A, Kosior DA, Wolfshaut-Wolak R, et al. Quality of Life in Patients with Coronary Artery Disease-Multicenter POLASPIRE II Study. J Clin Med. 2024, 13, 3630.
- Dibben GO, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD, et al. Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. Eur Heart J. 2023, 44, 452–69.
- Staniute M, Brozaitiene J, Bunevicius R. Effects of Social Support and Stressful Life Events on Health-Related Quality of Life in Coronary Artery Disease Patients. J Cardiovasc Nurs. 2013, 28, 83.
- Lee YM, Kim RB, Lee HJ, Kim K, Shin MH, Park HK, et al. Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: a cross-sectional study. Health Qual Life Outcomes. 2018, 16:100.
- Krack G, Holle R, Kirchberger I, Kuch B, Amann U, Seidl H. Determinants of adherence and effects on health-related quality of life after myocardial infarction: a prospective cohort study. BMC Geriatr. 2018, 18, 136.
- Nouamou I, Mourid ME, Ragbaoui Y, Habbal R. [Medication adherence among elderly patients with coronary artery disease: our experience in Morocco]. Pan Afr Med J. 2019, 32, 8.
- Zakeri MA, Tavan A, Nadimi AE, Bazmandegan G, Zakeri M, Sedri N. Relationship Between Health Literacy, Quality of Life, and Treatment Adherence in Patients with Acute Coronary Syndrome. HLRP Health Lit Res Pract. 7, e71-9.
- Jl A, Cd A, Em A, Cr B, Rm C, De C, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol.
- Guermazi M, Allouch C, Yahia M, Huissa TBA, Ghorbel S, Damak J, et al. Translation in Arabic, adaptation and validation of the SF-36 Health Survey for use in Tunisia. Ann Phys Rehabil Med. 2012, 55, 388–403.

|
Socio-demographic and economic characteristics Age Gender Male Female Marital status Married Single Level of education Illiterate instructed Living environment Urban Rural Occupation Employed Retried/jobless Insurance coverage Yes No Habits Smoking Physical activity |
62.7±12.8 Y/O 21% 79% 77% 23% 16% 84% 22% 78% 50% 50% 31% 69% 24% 41% |
|
Clinical characteristics: Comorbidities HTA Diabetes Dyslipidemia Obesity Chronic kidney disease Stroke Number of previous hospitalization 1 time 2-4 times ≥ 5 times |
60.7% 62% 73.3% 46.7% 45.3% 4% 24.7% 69.3 6% |
|
Echocardiographic findings Midely reduced LVEF Preserved LVEF |
39% 61% |
|
Angiographic data Coronary status One vessel Two vessels Three vessels Number of implanted stents One Two stents Three or more stents |
37% 43% 20% 37.3% 39% 22.7% |
|
Therapeutic aspects Number of medications >5 <5 Adherence to optimal treatment Optimal Not optimal |
74% 26% 73.3% 26.7% |
| MCS | P | PCS | p | SF36 | p | |
|
Comorbidities Tobacco Yes No Diabetes Yes No Arterial hypertension Yes No Dyslipidemia Yes No Obesity Yes No Chronic kidney disease Yes No Stroke Yes No |
56.2 47.3 51.3 57.1 54.2 52.4 54.4 50.5 38.8 66.3 53.8 53.2 54.6 53.4 |
0.031 0.168 0.672 0.384 <0.001 0.880 0.910 |
65.6 51.9 56.2 69.8 58.0 66.6 59.4 66.7 45.7 75.1 55.1 66.6 54.4 61.7 |
0.001 0.001 0.044 0.120 <0.001 0.005 0.494 |
67.5 56.9 60.4 70.7 62.5 66.8 63.3 67.1 49.2 77.5 60.7 67.3 59.3 64.5 |
0.005 0.004 0.241 0.343 <0.001 0.064 0.571 |
|
Number of previous hospitalizations 1 2-4 ≥5 |
47.1 56.8 41.2 |
0.039 |
66.6 61.7 36.4 |
0.005 |
66.4 65.2 44.9 |
0.020 |
|
Reason of hospitalization Stemi Yes No Nstemi Yes No Heart failure Yes No Chronic coronary syndrome Yes No |
50.9 54.8 54.3 52.3 46.1 55.8 52.6 53.6 |
0.376 0.623 0.041 0.888 |
58.4 62.8 25.3 60.3 48.1 65.6 62.1 61.3 |
0.318 0.681 <0.001 0.908 |
61.5 65.7 64.5 63.1 53.4 67.7 67.4 64.0 |
0.265 0.876 <0.001 0.575 |
|
Coronary status One vessel disease Two vessels disease Three vessels disease |
51.2 57.3 49.6 |
0.262 |
66.3 62.2 50.3 |
0.019 |
67.2 66.3 54.4 |
0.019 |
|
Left ventricular ejection fraction <40% 40-50% >50% |
32.9 56.6 54.1 |
0.021 |
34.5 59.5 65.3 |
0.001 |
43.1 63.7 66.9 |
0.004 |
|
Therapeutic aspects Smoking cessation Yes No Regular physical activity Yes No Optimal medical treatment Yes No Treatment adherence Yes No |
56.7 47.4 55.9 51.8 54.4 51.0 54.6 49.9 |
0.727 0.324 0.462 0.327 |
68.3 52.1 69.9 55.6 65.1 51.2 63.9 53.5 |
0.099 <0.001 0.03 0.033 |
68.6 57.1 69.3 60.7 66.8 57.2 66.3 58.0 |
0.424 0.017 0.016 0.045 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).